CCR5-Δ32 gene deletion in HIV-1 infected patients
- 1 September 1997
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 350 (9079) , 741-742
- https://doi.org/10.1016/s0140-6736(05)63552-0
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Dual effect of CCR5 Δ32 gene deletion in HIV-1-infected patientsThe Lancet, 1997
- The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progressionNature Medicine, 1997
- Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individualsAIDS, 1997
- Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified RiskMolecular Medicine, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996